Molecular and Cytogenetic Studies in a Child with Burkitt Lymphoma and Ataxia-Telangiectasia Syndrome Harboring MYC Overexpression and Partial Trisomy 8

참고문헌 (10)

1. Greenought A, "New clues to the molecular pathogenesis of Burkitt lymphoma revealed through next-generation sequencing", Curr Opin Hematol, 21, pp.326~332 (2014)[DOI]
2. De Souza MT, "Conventional and molecular cytogenetic characterization of Burkitt lymphoma with bone marrow involvement in Brazilian children and adolescents", Pediatr Blood Cancer, 61, pp.1422~1469 (2014)[DOI]
3. Swerdlow SH, "The 2016 revision of the World Health Organization classification of lymphoid neoplasms", Blood, 127, pp.2375~2390 (2016)[DOI]
4. Hummel M, "Molecular mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling", N Engl J Med, 354, pp.2419~2430 (2006)[DOI]
5. Onnis A, "Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma", PloS One, 23, pp.909~920 (2010)
6. Leucci E, "MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenic mechanism involving miRNA deregulation", J Pathol, 216, pp.440~450 (2008)[DOI]
7. Robertus JL, "miRNA profiling in B non-Hodgkin lymphoma: a MYC-related miRNA profile characterizes Burkitt lymphoma", Br J Haematol, 149, pp.896~899 (2010)[DOI]
8. Schoenaker MHD, "Treatment of acute leukemia in children with ataxia-telangiectasia (A-T)", Eur J Med Genet, 59, pp.641~646 (2016)[DOI]
9. Sandlund JT, "Pilot study of modified LMB-based therapy for children with ataxia-telangiectasia and advanced stage high grade mature b-cell malignancies", Pediatr Blood Cancer, 61, pp.360~362 (2014)[DOI]
10. Vera-Lozada G, "Analysis of biological and technical variability in gene expression assays from formalin-fixed paraffin-embedded classical Hodgkin lymphomas", Exp Mol Pathol, 97, pp.433~439 (2014)[DOI]

관련 논문AI추천